What is myocardial infarction
myocardial infarction heart attack diagram pathophysiology

A pathophysiology diagram illustrating the intracellular signaling pathways in endothelial cells (ECs) activated following myocardial infarction (MI). The visual highlights the cellular response to ischemia and autocrine/paracrine signals from various heart cell populations (cardiomyocytes, fibroblasts, macrophages). Key pathways depicted include hypoxia-induced HIF-1α/HIF-1β stabilization, and activation of Wnt, JAK/STAT, PI3K/AKT, and eNOS/NO systems. The diagram emphasizes VEGF-A binding to VEGFR2, which triggers the PLC-IP3/DAG cascade, leading to Ca2+ release from the endoplasmic reticulum via IP3R and subsequent store-operated calcium entry (SOCE) through Orai and TRPC channels. These calcium signals and transcription factors drive the expression of pro-angiogenic genes like VEGF and DLL4. The model further illustrates the Notch signaling mechanism where DLL4 on a 'tip cell' activates Notch1/NICD in an adjacent 'stalk cell' (expressing Hes1/Hey1). The cumulative educational focus is on the hallmarks of angiogenesis: increased permeability, proliferation, migration, and tube formation essential for ischemic myocardial healing.

This pathophysiology diagram illustrates the process of cell sheet engineering for myocardial repair in ischemic heart disease. The multi-stage flowchart begins with stem cells releasing extracellular vesicles and cytokines. These cells are cultivated in a 37°C temperature-responsive culture dish, transitioning to room temperature to facilitate cell sheet formation. The resulting biological scaffold is then transplanted onto a heart with a white-shaded area representing myocardial infarction. Magnified 'Treatment Area' views detail the therapeutic mechanisms: Angiogenesis, showing the interaction between the fibrous cell sheet, transparent vesicles/cells, and the underlying vasculature; and Regulation of Inflammation, depicting immune cells and molecular signaling at the transplant site. This infographic summarizes stem cell-based regenerative therapy, focusing on paracrine signaling, tissue engineering, and vascularization strategies for treating damaged cardiac tissue.

This pathophysiology diagram illustrates the chronological progression of tissue and cellular events following a myocardial infarction (MI), divided into four distinct stages. Stage I (Ischemia) shows an intact heart model. Stage II (Hypoxia) depicts the onset of cell death characterized by decreased ATP and increased reactive oxygen species (ROS) during reoxygenation, showing irregular, red-colored cardiomyocytes adjacent to a damaged capillary. Stage III (Inflammation) visualizes the early revascularization and immune response, including the phagocytosis of dead cell debris by macrophages (large irregular purple cells) and the infiltration of smaller leukocytes. Stage IV (Termination/Reparative phase) demonstrates myocardial regeneration and cardiosclerosis, where dead cells are replaced by dense white fibrous tissue (scarring) and surviving cardiomyocytes exhibit hypertrophy and more organized alignment. This educational infographic captures the transition from acute ischemic injury through the inflammatory cascade to chronic tissue remodeling and fibrosis, relevant for cardiovascular pathology and rehabilitative medicine study.

| Artery | % of MIs | Area infarcted |
|---|---|---|
| Left anterior descending (LAD) | 40-50% | Anterior LV wall, anterior 2/3 of septum, apex |
| Right coronary artery (RCA) | 30-40% | Right ventricle, inferior/posterior LV |
| Left circumflex (LCX) | 15-20% | Lateral left ventricle |
| Type | Description |
|---|---|
| STEMI | ST-elevation MI - complete occlusion, full-thickness (transmural) infarct. Requires immediate reperfusion. |
| NSTEMI | Non-ST-elevation MI - partial occlusion, subendocardial infarct. Confirmed by elevated troponins without ST elevation. |
| Unstable Angina (UA) | Ischemia without biomarker elevation. Part of the ACS spectrum. |
Important: Women, diabetics, and post-operative patients often present atypically (without classic chest pain), more commonly with dyspnea, fatigue, or back pain.

What should be disposed in different colors of bio degradable bin in hospital
hospital biomedical waste color coded bins categories disposal guidelines 2024
hospital biomedical waste color coded bins segregation chart

A clinical photograph of a modern Computed Tomography (CT) scanner set in a diagnostic imaging suite. The image features a white Siemens CT gantry with a large central bore and integrated digital display at the top. A motorized patient table extends from the gantry, equipped with a red protective cover and a contoured purple headrest. The clinical environment is further detailed by the presence of a color-coded waste segregation system consisting of red, yellow, blue, and black disposal bins along the back wall, beneath a medical facility poster. This visual provides educational context for diagnostic radiology equipment, the mechanics of cross-sectional imaging (slices), and the standard clinical setup required for trauma, oncology, and neurology diagnostics. The configuration illustrates the essential components used in human medical imaging for identifying internal pathologies such as fractures, tumors, or vascular abnormalities.

This diagnostic comparison chart utilizes brain surface plots derived from functional MRI (fMRI) data to visualize network-specific topological changes in Alzheimer’s disease (AD) and behavioral variant frontotemporal dementia (bvFTD) compared to healthy controls (HC). The image displays two primary graph theoretical metrics: Within-module degree (top rows), indicating intra-network connectedness, and Participation coefficient (bottom rows), representing inter-network distinctiveness (segregation). The cortical maps use a color-coded scale where orange denotes significant increases and blue denotes significant decreases (p < 0.05). In AD patients vs. HC, there is a prominent reduction in within-module degree in posterior regions like the precuneus and posterior cingulate cortex, alongside increased participation coefficients in the control and somatomotor networks, suggesting reduced network segregation. In contrast, bvFTD patients vs. HC exhibit significant connectivity decreases in frontal and insular regions within the salience/ventral attention network (SVAN). The head-to-head comparison (AD vs. bvFTD) further illustrates the divergent neurodegenerative patterns, emphasizing the posterior-dominant breakdown in AD versus the anterior/insular vulnerability in bvFTD.

This Comparison Chart displays brain network community detection results from healthy adults, contrasting Functional Networks (left) and Structural Networks (right). The figure utilizes 3D cortical surface renderings in medial (top row) and lateral (bottom row) views. A color-coded visual key identifies six primary brain systems: Red (Default Mode Network), Pink (Cingulo-opercular), Yellow (Fronto-parietal), Dark Blue (Visual), Light Blue (Somatomotor), and Dark Red (Orbitofrontal/Limbic). Each cortical region is colored based on its assigned community membership. Arrows highlight specific anatomical regions, such as the posterior cingulate/precuneus and medial prefrontal cortex, where the spatial extent of communities like the Default Mode and Cingulo-opercular networks differs between the functional and structural modalities. The diagrams illustrate that while both network types share similar large-scale organizational principles, the functional connectivity patterns show higher system-specific segregation compared to the structural connectivity patterns. This visual is designed for advanced medical education in neuroanatomy and functional neuroimaging, specifically regarding the relationship between structural connectomics and resting-state fMRI networks.
https://www.diginerve.com/blogs/a-guide-to-different-types-o…
| Sub-type | Examples |
|---|---|
| Human Anatomical Waste | Body parts, organs, limbs, tissues, fetuses |
| Animal Anatomical Waste | Animal body parts from veterinary/research settings |
| Discarded or Expired Medicine | Pharmaceuticals past expiry date |
| Microbiology & Lab Waste | Cultures, specimens, vaccine preparations, lab waste |
| Chemical Waste (Yellow-e) | Expired liquid chemicals, X-ray developer (spent hypo) stored in yellow container |
| Contaminated linen/bedding | Blood-soaked sheets, dressings, bandages with body fluids |
| Blood bags and blood products | Used/expired blood bags |
| Cytotoxic/Chemotherapy waste | All chemo drugs, cytotoxic/mutagenic agents |
| Examples |
|---|
| Syringes without needles (after needle removal) |
| IV tubes and sets, catheters |
| Soiled gloves, gowns, drapes |
| Urine bags, blood transfusion bags (empty) |
| Contaminated plastics |
| Specimen/sample collection containers (plastic) |
| Examples |
|---|
| Needles, syringes with fixed needles |
| Scalpels and surgical blades |
| Lancets |
| Broken glass with contamination |
| Metal implants / sharp metallic objects |
The CDC estimates ~385,000 needlestick injuries occur in hospital workers annually - proper white bin use is the primary prevention tool.
| Examples |
|---|
| Broken or discarded glass (non-contaminated or decontaminated) |
| Glass slides, vials, ampoules |
| Metallic implants removed from patients |
| Medicine vials (glass) |
| Color | Category | Key Contents | Treatment |
|---|---|---|---|
| 🟡 Yellow | Anatomical / Pharmaceutical / Chemo | Body parts, expired medicines, lab cultures, blood bags, chemo drugs | Incineration / Deep burial |
| 🔴 Red | Contaminated recyclable plastics | Syringes (no needle), IV sets, gloves, catheters, urine bags | Autoclave → Recycle |
| ⬜ White | Sharps | Needles, blades, scalpels, lancets, broken glass (contaminated) | Autoclave → Shred/Destroy |
| 🔵 Blue | Glassware / Metal implants | Glass vials, ampoules, slides, metallic implants | Disinfect → Secured landfill |
| Color | Waste Type | Examples | Treatment |
|---|---|---|---|
| 🔴 Red | Infectious soft waste | Contaminated gloves, gowns, IV tubing, syringes (no needle) | Autoclave → landfill/recycle |
| 🟡 Yellow | Pathological + chemo waste | Tissues, body parts, blood bags, lab cultures, chemo/cytotoxic drugs | High-temp incineration |
| ⬜ White/Translucent | Sharps | Needles, scalpels, lancets | Autoclave → shred |
| 🔵 Blue | Non-hazardous pharma / glass | Non-RCRA expired drugs, glass | Landfill or incineration |
| ⬛ Black | RCRA hazardous pharma | Chemotherapy drugs meeting RCRA hazardous waste criteria | Regulated hazardous waste incineration |
I have a interview for DMO in hospital only inpatient ward duties no emergency duty or casuality duties What questions doctor can ask me regarding my DMO job
DMO duty medical officer inpatient ward interview questions hospital India
Expected answer: Reviewing all admitted patients each shift, checking vitals charts, reviewing nursing notes, countersigning/updating medication orders, updating progress notes, calling consultants when required, declaring patients fit for procedures or discharge, documenting in medical records, and handover to the next DMO.
DMO manages day-to-day ward monitoring and implements treatment plans already made by the consultant. The consultant makes definitive treatment decisions; the DMO executes and watches for changes in patient condition.
Hand over all unstable or flagged patients verbally AND in writing - cover current vitals, recent changes, pending investigations, and any expected events. Use SBAR (Situation, Background, Assessment, Recommendation) format.
Patients who deteriorated overnight, those with abnormal vitals, post-operative patients in the first 24-48 hours, patients awaiting urgent reports, and those scheduled for procedures or discharge today.
Go immediately, put the patient on oxygen (start with nasal prongs at 2-4 L/min, escalate to face mask/NRM if needed), check RR, HR, BP, auscultate chest, check if new onset or gradual, review current medications (sedatives?), call for ABG if available, and escalate to the consultant if no improvement.
Temperature, pulse, blood pressure, respiratory rate, SpO₂, urine output (in relevant patients), pain score, GCS (if neurological case), wound condition (if post-op), and input/output charts.
It's a scoring system based on 6-7 vital parameters. A rising score (typically ≥5) triggers escalation. It helps identify patients deteriorating before a crisis happens.
When there is: persistent hypoxia not responding to supplemental oxygen, hemodynamic instability (BP not responding to fluids), falling GCS/altered consciousness, worsening sepsis criteria, or any condition requiring invasive monitoring or ventilatory support.
Assess urgency - if it's a critical drug (e.g., insulin, anticoagulant, antiepileptic), escalate immediately to pharmacy and nursing in-charge. Document the issue. If unavailable, contact the consultant for an alternative. Never skip documentation.
Stop the suspected drug, assess severity (mild/anaphylaxis), give treatment accordingly (antihistamine, steroids, adrenaline for anaphylaxis), document in the patient's file, fill the ADR reporting form (Yellow Card / Pharmacovigilance), and inform the consultant.
Right Patient, Right Drug, Right Dose, Right Route, Right Time. (Some add: Right Documentation and Right Reason.)
Hold warfarin, inform consultant, monitor closely for signs of bleeding, check for interacting drugs/diet changes, and repeat INR. Vitamin K may be given per consultant advice.
Call for help immediately, check for responsiveness and breathing, start BLS if no pulse/breathing, call for crash cart, attach defibrillator, follow ACLS protocol, inform consultant and senior, document time of events.
Wind, Water, Wound, Walking, Wonder drugs (the "5 Ws"):
- Day 1-2: Wind - atelectasis, pneumonia
- Day 3-5: Water - UTI, IV line infection
- Day 5-7: Wound - surgical site infection
- Day 7+: DVT/PE Examine accordingly, send cultures if indicated, review antibiotics with consultant.
If conscious and able to swallow - give 15g oral glucose (juice/glucose tablets). Recheck in 15 minutes. If unconscious - IV 25 mL of 50% dextrose (D50) or 150 mL of 10% dextrose, then start 10% dextrose infusion. Identify the cause (excess insulin? missed meal?), adjust insulin orders, and inform consultant.
Check hydration status and IV fluid input, check if catheter is blocked (flush/replace if catheterized), palpate for bladder distension, review medications (opioids cause urinary retention), check electrolytes/creatinine - if still no output after correcting factors, inform consultant, consider catheterization if not already done.
Listen respectfully to the family's concerns, explain the medical necessity of continued admission in simple language, involve the consultant in the conversation, document the discussion. If they insist on leaving against medical advice (LAMA), explain risks clearly, have them sign the LAMA form, and document thoroughly.
Date and time, doctor's name and signature, patient's current complaints, examination findings, investigation results reviewed, assessment (diagnosis/changes), plan (medication changes, orders, referrals), and whether consultant was informed.
Confirm death (check for pulse, breathing, pupil response), note the time of death, inform the consultant, inform the family with empathy, complete the Death Certificate (if the cause is known and not suspicious), hand over the body to the mortuary as per hospital protocol, document everything, and inform the ward in-charge/nursing staff.
Leave Against Medical Advice. Document the patient's stated reason, risks explained to them, names of witnesses, and get the patient's signature on the LAMA form. A patient has the legal right to leave as long as they have decision-making capacity.
When the death is sudden/unexplained, within 24 hours of admission, post-operative death (especially within 24-48 hours), suspicious/medicolegal circumstances, injury-related death, or poisoning. In these cases, refer to the Medical Superintendent and/or police for medico-legal autopsy.
Isolate the patient if indicated (e.g., MRSA, C. difficile), send appropriate cultures, review antibiotic policy with the consultant/microbiologist, report to the hospital infection control committee, implement contact precautions, and educate nursing staff on hand hygiene.
Gloves and gown at minimum. Add a mask if respiratory precautions apply. Remove PPE before leaving the patient's room and perform hand hygiene with soap and water or sanitizer.
Wash the wound immediately with soap and water (do not suck the wound), report to the occupational health/nodal officer, get baseline serology (HIV, HBV, HCV) for both source patient and injured staff, start PEP (Post-Exposure Prophylaxis) within 2 hours for HIV risk, document in the incident report.
Use SBAR format:
- Situation: "Dr. X, patient in Bed 12, Mr. Y, is deteriorating."
- Background: "He was admitted 3 days ago with pneumonia, on IV antibiotics."
- Assessment: "His SpO₂ has dropped to 90% on 4L O₂, RR is 28, BP 90/60."
- Recommendation: "I think he may need ICU transfer. Can you please come and review?"
Remain calm and professional, focus on the patient's best interest, clarify your clinical reasoning, escalate to the consultant if the disagreement affects patient safety, and document the exchange.
Focus on: interest in inpatient clinical medicine, desire to develop systematic patient monitoring skills, building clinical decision-making in a structured ward environment.
Prioritize by acuity using vitals flags. Delegate appropriate tasks to nursing staff. Use a structured checklist. Communicate early if the workload is unsafe. Document as you go rather than at the end of the shift.
Use a STAR answer (Situation, Task, Action, Result). Be specific, honest, and focus on what you learned.
Never act beyond your competence level. Call the consultant or senior on call. It is better to make one call and be corrected than to miss something serious. Document that you consulted.
| Topic | Why It Matters |
|---|---|
| Normal vitals and alarm limits | You'll be asked about these |
| ABG interpretation basics | Common ward skill |
| Insulin sliding scale management | Diabetic patients are very common |
| Blood transfusion reactions | Very common ward scenario |
| Post-op care basics (Day 1, 2, 3) | Especially surgical wards |
| DVT prophylaxis in admitted patients | Standard of care |
| Common ward drug dosages (heparin, dextrose, IV fluids) | Practical knowledge |
| SBAR communication | Key communication tool |
| Documentation standards | Legal requirement |
| Biomedical waste rules | Already covered above |